Viewing Study NCT04972656


Ignite Creation Date: 2025-12-24 @ 11:28 PM
Ignite Modification Date: 2026-01-05 @ 6:37 PM
Study NCT ID: NCT04972656
Status: RECRUITING
Last Update Posted: 2022-09-28
First Post: 2021-07-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment With Ambrisentan in Patients With Borderline Pulmonary Arterial Hypertension
Sponsor: Nanjing First Hospital, Nanjing Medical University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pulmonary Arterial Hypertension View
Keywords: